Loxo Oncology Company
Loxo Oncology is a biopharmaceutical company focused on targeted cancer therapies for genetically-defined patient populations.
Technology:
Cancer
Industry:
PharmTech
Headquarters:
New York, New York, United States
Founded Date:
2013
Employees Number:
11-50
Funding Status:
M&A
Estimated Revenue:
$100M to $500M
Register and Claim Ownership